{"id":205154,"date":"2020-11-09T00:23:09","date_gmt":"2020-11-08T23:23:09","guid":{"rendered":"https:\/\/tucuentavip.com\/es\/?p=205154"},"modified":"2020-11-07T09:44:29","modified_gmt":"2020-11-07T08:44:29","slug":"y-ahora-soberana-2","status":"publish","type":"post","link":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/","title":{"rendered":"Y ahora, Soberana 2"},"content":{"rendered":"<p><em>Los candidatos vacunales de Cuba, Soberana 01 y Soberana 02 contra el SARS-CoV-2, se encuentran ya en estudio cl\u00ednico. <\/em><\/p>\n<p>&nbsp;<\/p>\n<p><strong> <img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-199944\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/05\/Coronavirus-covid-ciudada-gente-Pixabay-e1589168727933.jpg\" alt=\"\" width=\"435\" height=\"290\" \/><a href=\"http:\/\/Danay Galletti Hern\u00e1ndez\">Danay Galletti Hern\u00e1ndez<\/a><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Ambas son vacunas de subunidades, usan como ant\u00edgeno la prote\u00edna viral, contienen componentes que mejoran la respuesta inmune y se basan en plataformas tecnol\u00f3gicas validadas en seres humanos.<\/p>\n<p>Desarrolladas por el <a href=\"https:\/\/www.finlay.edu.cu\/en\/\">Instituto Finlay de Vacunas (IFV)<\/a> de La Habana, existe un proceso com\u00fan para las dos que es la obtenci\u00f3n del ant\u00edgeno viral y la diferencia m\u00e1s perceptible reside en que la Soberana 02 es una vacuna conjugada, en la cual el ant\u00edgeno del virus se encuentra enlazado qu\u00edmicamente al toxoide tet\u00e1nico, seg\u00fan refleja la p\u00e1gina de la instituci\u00f3n cient\u00edfica.<\/p>\n<p>Eso \u00faltimo constituye una innovaci\u00f3n pues no existen precedentes dentro de los 249 proyectos de vacunas que se ejecutan a nivel mundial.<\/p>\n<p>Los expertos informan que las vacunas conjugadas poseen dos peculiaridades: inducen inmunidad de larga duraci\u00f3n y los anticuerpos generados protegen de la enfermedad e impiden la colonizaci\u00f3n de la orofaringe de las personas vacunadas.<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-200905 alignleft\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/06\/Alcance-de-la-solid-Coronavirus-covid-Pixabay-2-1024x683.jpg\" alt=\"\" width=\"463\" height=\"309\" \/><\/strong>Los resultados del candidato vacunal Soberana 01 se esperan para enero de 2021 y, si bien no se observan reacciones adversas o efectos graves, a\u00fan falta evaluar el comportamiento del ensayo y el procesamiento de las muestras, para comprobar si realmente hay anticuerpos.<\/p>\n<p>Por tanto, el equipo de trabajo prev\u00e9 que durante el primer semestre de ese a\u00f1o se podr\u00e1 comenzar a vacunar a la poblaci\u00f3n.<\/p>\n<p>Directivos del IFV han informado en medios locales que los participantes en el estudio del candidato Soberana 01, cuya funci\u00f3n es estimular potentemente la respuesta inmune, ya recibieron las dos dosis, tras lo cual se comprob\u00f3 la seguridad de la misma y la presencia de pocos efectos adversos, todos ligeros.<\/p>\n<p>A la par, desarrollan otras tres formulaciones del candidato vacunal que comenzaron el ensayo Fase 1, con el objetivo de evaluar la respuesta inmune y decidir cu\u00e1l es la mejor formulaci\u00f3n para avanzar a etapas superiores de ensayos cl\u00ednicos. Respecto a la Soberana 02, el 27 de octubre \u00faltimo el Cecmed aprob\u00f3 el ensayo cl\u00ednico Fase 1 de ese candidato vacunal.<\/p>\n<p>\u201cAunque se aceleran o se superponen procesos por la exigencia y emergencia de salud, no se violan las etapas, algunas de ellas son las evaluaciones precl\u00ednicas en animales, estudios toxicol\u00f3gicos, implementaci\u00f3n de t\u00e9cnicas anal\u00edticas de confirmaci\u00f3n de que ese producto cumple con los requisitos y regulaciones farmac\u00e9uticas para su uso en humanos, entre otras\u00bb.<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-199152\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/04\/Coronavirus-tax-computador-dinero-enfer-inter-Pixabay-e1586070001694.jpg\" alt=\"\" width=\"441\" height=\"294\" \/><\/strong>Tal fue la declaraci\u00f3n a Prensa Latina de Gerardo Guill\u00e9n, Director de Investigaciones Biom\u00e9dicas del CIGB.<\/p>\n<p>En la investigaci\u00f3n de estos candidatos vacunales intervienen instituciones cient\u00edficas del Grupo de las Industrias Biotecnol\u00f3gica y Farmac\u00e9utica de Cuba (BioCubaFarma), el Ministerio de Salud P\u00fablica, la Universidad de la Habana y los hospitales, donde se eval\u00faa el comportamiento natural de la enfermedad y la respuesta al tratamiento en los pacientes.<\/p>\n<p>Una de las ventajas y fortalezas de la biotecnolog\u00eda y de la ciencia en Cuba es que \u201cno hay competencia entre las instituciones, sino integraci\u00f3n. La experiencia de todos contribuye al avance m\u00e1s r\u00e1pido de los proyectoss pueden servir para los diferentes candidatos vacunales\u201d<\/p>\n<p>En el enfrentamiento a la Covid-19 les han ayudado otras experiencias en situaciones epidemiol\u00f3gicas complejas como: el dengue, la meningitis de origen bacteriano y el control del SIDA. <a href=\"https:\/\/www.prensa-latina.cu\/\">(PL)<\/a><\/p>\n<p><em><a href=\"http:\/\/www.pixabay.com\/\">(Fotos: Pixabay)<\/a><\/em><\/p>\n<div class=\"twttr_buttons\"><div class=\"twttr_twitter\">\n\t\t\t\t\t<a href=\"http:\/\/twitter.com\/share?text=Y+ahora%2C+Soberana+2\" class=\"twitter-share-button\" data-via=\"\" data-hashtags=\"\"  data-size=\"default\" data-url=\"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/\" data-dnt=\"true\" data-related=\"\" target=\"_blank\">Tweet<\/a>\n\t\t\t\t<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Los candidatos vacunales de Cuba, Soberana 01 y Soberana 02 contra el SARS-CoV-2, se encuentran ya en estudio cl\u00ednico. &nbsp; Danay Galletti Hern\u00e1ndez &nbsp; Ambas son vacunas de subunidades, usan como ant\u00edgeno la prote\u00edna viral, contienen componentes que mejoran la respuesta inmune y se basan en plataformas tecnol\u00f3gicas validadas en [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":200717,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,7,31,29],"tags":[],"class_list":["post-205154","post","type-post","status-publish","format-standard","has-post-thumbnail","category-en-foco","category-opinion","category-salud","category-vida-de-hoy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Y ahora, Soberana 2 - ThePrisma.co.uk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Y ahora, Soberana 2 - ThePrisma.co.uk\" \/>\n<meta property=\"og:description\" content=\"Los candidatos vacunales de Cuba, Soberana 01 y Soberana 02 contra el SARS-CoV-2, se encuentran ya en estudio cl\u00ednico. &nbsp; Danay Galletti Hern\u00e1ndez &nbsp; Ambas son vacunas de subunidades, usan como ant\u00edgeno la prote\u00edna viral, contienen componentes que mejoran la respuesta inmune y se basan en plataformas tecnol\u00f3gicas validadas en [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/\" \/>\n<meta property=\"og:site_name\" content=\"ThePrisma.co.uk\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-08T23:23:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"468\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ThePrisma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@The_Prisma\" \/>\n<meta name=\"twitter:site\" content=\"@The_Prisma\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"ThePrisma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/\"},\"author\":{\"name\":\"ThePrisma\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/person\\\/24f5091d3dc50052d73cbea6ecd09df7\"},\"headline\":\"Y ahora, Soberana 2\",\"datePublished\":\"2020-11-08T23:23:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/\"},\"wordCount\":583,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg\",\"articleSection\":[\"En Foco\",\"Opini\u00f3n\",\"Salud\",\"Vida de hoy\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/\",\"name\":\"Y ahora, Soberana 2 - ThePrisma.co.uk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg\",\"datePublished\":\"2020-11-08T23:23:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg\",\"contentUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg\",\"width\":640,\"height\":468},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/11\\\/09\\\/y-ahora-soberana-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/theprisma.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Y ahora, Soberana 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/\",\"name\":\"ThePrisma.co.uk\",\"description\":\"Ethical and Independent Journalism\u2026 Journalism for immigrants\",\"publisher\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/theprisma.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\",\"name\":\"ThePrisma.co.uk\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-TP-May-3-2026.jpg\",\"contentUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-TP-May-3-2026.jpg\",\"width\":2171,\"height\":353,\"caption\":\"ThePrisma.co.uk\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ThePrismaTheMulticulturalNewspaper\",\"https:\\\/\\\/x.com\\\/The_Prisma\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/person\\\/24f5091d3dc50052d73cbea6ecd09df7\",\"name\":\"ThePrisma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"caption\":\"ThePrisma\"},\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/author\\\/theprisma\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Y ahora, Soberana 2 - ThePrisma.co.uk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/","og_locale":"es_ES","og_type":"article","og_title":"Y ahora, Soberana 2 - ThePrisma.co.uk","og_description":"Los candidatos vacunales de Cuba, Soberana 01 y Soberana 02 contra el SARS-CoV-2, se encuentran ya en estudio cl\u00ednico. &nbsp; Danay Galletti Hern\u00e1ndez &nbsp; Ambas son vacunas de subunidades, usan como ant\u00edgeno la prote\u00edna viral, contienen componentes que mejoran la respuesta inmune y se basan en plataformas tecnol\u00f3gicas validadas en [&hellip;]","og_url":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/","og_site_name":"ThePrisma.co.uk","article_publisher":"https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper","article_published_time":"2020-11-08T23:23:09+00:00","og_image":[{"width":640,"height":468,"url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg","type":"image\/jpeg"}],"author":"ThePrisma","twitter_card":"summary_large_image","twitter_creator":"@The_Prisma","twitter_site":"@The_Prisma","twitter_misc":{"Escrito por":"ThePrisma","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#article","isPartOf":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/"},"author":{"name":"ThePrisma","@id":"https:\/\/theprisma.co.uk\/#\/schema\/person\/24f5091d3dc50052d73cbea6ecd09df7"},"headline":"Y ahora, Soberana 2","datePublished":"2020-11-08T23:23:09+00:00","mainEntityOfPage":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/"},"wordCount":583,"commentCount":0,"publisher":{"@id":"https:\/\/theprisma.co.uk\/#organization"},"image":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#primaryimage"},"thumbnailUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg","articleSection":["En Foco","Opini\u00f3n","Salud","Vida de hoy"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/","url":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/","name":"Y ahora, Soberana 2 - ThePrisma.co.uk","isPartOf":{"@id":"https:\/\/theprisma.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#primaryimage"},"image":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#primaryimage"},"thumbnailUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg","datePublished":"2020-11-08T23:23:09+00:00","breadcrumb":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#primaryimage","url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg","contentUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/06\/Alergia-coronavirus-covid-tierra-planeta-Pixabay-1.jpg","width":640,"height":468},{"@type":"BreadcrumbList","@id":"https:\/\/theprisma.co.uk\/es\/2020\/11\/09\/y-ahora-soberana-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/theprisma.co.uk\/"},{"@type":"ListItem","position":2,"name":"Y ahora, Soberana 2"}]},{"@type":"WebSite","@id":"https:\/\/theprisma.co.uk\/#website","url":"https:\/\/theprisma.co.uk\/","name":"ThePrisma.co.uk","description":"Ethical and Independent Journalism\u2026 Journalism for immigrants","publisher":{"@id":"https:\/\/theprisma.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/theprisma.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/theprisma.co.uk\/#organization","name":"ThePrisma.co.uk","url":"https:\/\/theprisma.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/theprisma.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2026\/05\/Logo-TP-May-3-2026.jpg","contentUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2026\/05\/Logo-TP-May-3-2026.jpg","width":2171,"height":353,"caption":"ThePrisma.co.uk"},"image":{"@id":"https:\/\/theprisma.co.uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper","https:\/\/x.com\/The_Prisma"]},{"@type":"Person","@id":"https:\/\/theprisma.co.uk\/#\/schema\/person\/24f5091d3dc50052d73cbea6ecd09df7","name":"ThePrisma","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","caption":"ThePrisma"},"url":"https:\/\/theprisma.co.uk\/es\/author\/theprisma\/"}]}},"_links":{"self":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/205154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/comments?post=205154"}],"version-history":[{"count":10,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/205154\/revisions"}],"predecessor-version":[{"id":205206,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/205154\/revisions\/205206"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/media\/200717"}],"wp:attachment":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/media?parent=205154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/categories?post=205154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/tags?post=205154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}